Blueprint Medicines Market Cap

SHA:600325 has a market cap or net worth of 13.19 billion as of August 5, 2025. Its market cap has decreased by -20.14% in one year.

Market Cap

13.19B

Enterprise Value

214.85B

Revenue

71.48B

Ranking

n/a

PE Ratio

16.51

Stock Price

$4.81

Market Cap Chart

Since June 22, 2004, SHA:600325's market cap has increased from 1.86B to 13.19B, an increase of 609.03%. That is a compound annual growth rate of 9.71%.

Market Cap History

Date	Market Cap	% Change
Aug 5, 2025	13.19B	-16.81%
Dec 31, 2024	15.85B	-20.11%
Dec 29, 2023	19.84B	3.45%
Dec 30, 2022	19.18B	50.50%
Dec 31, 2021	12.75B	-3.06%
Dec 31, 2020	13.15B	-20.69%
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Zhejiang China Commodities City Group	112.41B
Poly Developments and Holdings Group	94.33B
China Merchants Shekou Industrial Zone Holdings	78.31B
China Vanke	72.07B
Shanghai Zhangjiang Hi-Tech Park Development	50.60B
Hainan Airport Infrastructure	44.67B
Quzhou Xin'an Development	34.80B
Seazen Holdings	32.59B

Market Cap Rankings